Octreotide - NDC Database (Page 2)

85 records found
Page:First Page2Next PageLast Page
0781-3164 Oct 21, 1988
Octreotide Acetate 1000 ug/ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc
0781-3165 Oct 21, 1988
Octreotide Acetate 200 ug/ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc
0781-3166 Feb 04, 2014
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc
0781-3167 Feb 04, 2014
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc
0781-3168 Feb 04, 2014
Octreotide Acetate 500 ug/ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc
0781-9164 Oct 21, 1988
Octreotide Acetate 1000 ug/ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc
0781-9165 Oct 21, 1988
Octreotide Acetate 200 ug/ml Intravenous; Subcutaneous Injection, Solution by Sandoz Inc
23155-685 May 25, 2022
Octreotide Acetate 200 ug/ml Intravenous Injection by Heritage Pharmaceuticals Inc.
23155-686 May 25, 2022
Octreotide Acetate 1000 ug/ml Intravenous Injection by Heritage Pharmaceuticals Inc.
23155-687 May 25, 2022
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection, Solution by Heritage Pharmaceuticals Inc.
23155-688 May 25, 2022
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection, Solution by Heritage Pharmaceuticals Inc.
23155-689 May 25, 2022
Octreotide Acetate 500 ug/ml Intravenous; Subcutaneous Injection, Solution by Heritage Pharmaceuticals Inc.
25021-451 Dec 15, 2013
Octreotide Acetate 50 ug/ml Intramuscular; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
25021-452 Dec 15, 2013
Octreotide Acetate 100 ug/ml Intramuscular; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
25021-453 Dec 15, 2013
Octreotide Acetate 500 ug/ml Intramuscular; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
25021-454 Dec 15, 2013
Octreotide Acetate 200 ug/ml Intramuscular; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
25021-455 Dec 15, 2013
Octreotide Acetate 1000 ug/ml Intramuscular; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
25021-463 Apr 15, 2023
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
25021-464 Apr 15, 2023
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
25021-465 Apr 15, 2023
Octreotide Acetate 500 ug/ml Intravenous; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
Page:First Page2Next PageLast Page
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.